As on Wednesday, Rapport Therapeutics Inc (NASDAQ: RAPP) started slowly as it slid -0.96% to $30.34, before settling in for the price of $30.64 at the close. Taking a more long-term approach, RAPP posted a 52-week range of $6.43-$42.27.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 25.15%. This publicly-traded company’s shares outstanding now amounts to $47.65 million, simultaneously with a float of $28.76 million. The organization now has a market capitalization sitting at $1.45 billion. At the time of writing, stock’s 50-day Moving Average stood at $27.96, while the 200-day Moving Average is $18.35.
Rapport Therapeutics Inc (RAPP) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Rapport Therapeutics Inc’s current insider ownership accounts for 39.65%, in contrast to 68.44% institutional ownership. According to the most recent insider trade that took place on Dec 17 ’25, this organization’s Chief Executive Officer sold 5,833 shares at the rate of 29.64, making the entire transaction reach 172,877 in total value, affecting insider ownership by 567,913. Preceding that transaction, on Dec 17 ’25, Company’s Chief Executive Officer sold 5,083 for 29.63, making the whole transaction’s value amount to 150,632. This particular insider is now the holder of 30,895 in total.
Rapport Therapeutics Inc (NASDAQ: RAPP) Trading Performance Indicators
Let’s observe the current performance indicators for Rapport Therapeutics Inc (RAPP). It’s Quick Ratio in the last reported quarter now stands at 36.37.
In the same vein, RAPP’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.69, a figure that is expected to reach -0.66 in the next quarter, and analysts are predicting that it will be -3.54 at the market close of one year from today.
Technical Analysis of Rapport Therapeutics Inc (RAPP)
Through scrutinizing the latest numbers posted by the [Rapport Therapeutics Inc, RAPP], it can be observed that its last 5-days Average volume of 0.25 million was lower the volume of 0.37 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 48.28% While, its Average True Range was 53.35.
Raw Stochastic average of Rapport Therapeutics Inc (RAPP) in the period of the previous 100 days is set at 58.01%, which indicates a major rise in contrast to 53.35% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.79 that was lower than 1.95 volatility it exhibited in the past 100-days period.
